Y122
InvestorScreen: DoneContacts: To Do
We want people to live better and longer.
Y122 is a venture capital firm focused on biotechnology and life sciences, specifically targeting advancements in human healthspan and longevity.
San Francisco, California, United States
Venture Capital and Private Equity Principals
venture capital
healthcare, biotechnology
Healthcare
—
—
1
—
healthcare · extending human healthspan, longevity, biotechnology, lifespan extension
Done
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.